JPS61254510A - External agent for skin - Google Patents

External agent for skin

Info

Publication number
JPS61254510A
JPS61254510A JP60093815A JP9381585A JPS61254510A JP S61254510 A JPS61254510 A JP S61254510A JP 60093815 A JP60093815 A JP 60093815A JP 9381585 A JP9381585 A JP 9381585A JP S61254510 A JPS61254510 A JP S61254510A
Authority
JP
Japan
Prior art keywords
skin
iris
vitamin
pyridoxine
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60093815A
Other languages
Japanese (ja)
Other versions
JPH0582365B2 (en
Inventor
Yoshiko Sato
嘉子 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60093815A priority Critical patent/JPS61254510A/en
Publication of JPS61254510A publication Critical patent/JPS61254510A/en
Publication of JPH0582365B2 publication Critical patent/JPH0582365B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:A high-safety external agent for skin that contains pyridoxine and iris, thus showing excellent effect to prevent coarse skin, improve coarse skin and prevent symptoms of senility by inhibiting skins from sagging and delustering. CONSTITUTION:The objective agent contains pyridoxine (=vitamin B6) or its derivative such as hydrochloride, which has been used for prevention of coarse skins, and iris or its extract. The iris means its root, which contains iridine, fatty acids and tannin. The roots are pulverized, refluxed together with a lower alcohol and filtered. The filtrate is concentrated and the product is used together with the pyridoxine. The amount of pyridoxine is 0.005-2wt% based on the total agent and the amount of iris is preferably 0.001-5wt% on the dry basis.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は皮膚外用剤に関し、さらに詳しくは肌荒れを防
止し、肌荒れを改善する外、皮膚のたるみや艷の消失な
どを防いで老化を防止する効果に優れた、安全性の高い
皮膚外用剤に関する。
[Detailed Description of the Invention] Industrial Application Field The present invention relates to a skin preparation for external use, and more specifically, it has the effect of preventing skin roughness, improving skin roughness, and preventing aging by preventing skin sagging and loss of calluses. This invention relates to a highly safe topical preparation for the skin that has excellent properties.

従来の技術 化粧料などの皮膚外用剤には種々の薬効剤が配合−・ されており、肌荒れ防止や肌荒れ改善効果のある薬効剤
の開発が待望されているが、かかる効果を有する薬効剤
は現在までまだ見出されていない。
Conventional technology Cosmetics and other external skin preparations contain various medicinal agents, and the development of medicinal agents that have the effect of preventing and improving skin roughness is long awaited, but there are no medicinal agents that have such effects. It has not been discovered until now.

従来、ピリドキシン(即ち、ビタミンBe)又はその誘
導体は、肌荒れ改善に用いられてきたが、その効果はい
まだ十分でなかった。
Conventionally, pyridoxine (i.e., vitamin Be) or its derivatives have been used to improve rough skin, but the effects have not yet been sufficient.

発明が解決しようとする問題点 かかる現状に鑑み、本発明者らは肌荒れ防止及び肌荒れ
改善効果を有する皮膚外用剤を開発すべく鋭意研究を進
めた結果、アイリス又はその抽出液をピリドキシン又は
その誘導体と共に配合することによって、肌荒れ防止及
び肌荒れ改善効果に優れ、かつ皮膚のたるみや艷などの
消失を防いで老化を防止する効果に優れた皮膚外用剤が
得られることを見い出し、本発明を完成するに至った。
Problems to be Solved by the Invention In view of the current situation, the present inventors conducted intensive research to develop a skin preparation for external use that has the effect of preventing and improving skin roughness. The present inventors have discovered that by blending with the above ingredients, it is possible to obtain an external preparation for skin that is excellent in preventing and improving skin roughness, as well as in preventing aging by preventing the disappearance of skin sagging and calluses, and has completed the present invention. reached.

、問題点を解決するための手段 すなわち、本発明はピリドキシン又はその誘導体とアイ
リス又はその抽出液とを配合して成る皮膚外用剤を提供
するものである。
As a means for solving the problems, the present invention provides an external skin preparation comprising pyridoxine or a derivative thereof and iris or an extract thereof.

本発明に係る皮膚外用剤に配合されるアイリスはアヤメ
科のニオイアイリス、ムラサキアイリス、シボリアイリ
スなどのアイリスの根であり、イリジン、脂肪酸、タン
ニンなどが含まれている。これらのアイリスの根は、粉
末化して皮膚外用剤に配合しても良いし、適当な溶媒で
抽出した抽出液として配合しても良い。
The iris to be incorporated into the external skin preparation of the present invention is the root of iris of the Iridaceae family, such as odoriferous iris, purple iris, and iris iris, and contains irisine, fatty acids, tannins, and the like. These iris roots may be powdered and blended into external skin preparations, or may be blended as an extract extracted with an appropriate solvent.

アイリスの抽出液は、例えば水、メタノールやエタノー
ルのような低級アルコール又は含水低級アルコールなど
のような適当な溶媒中でアイリスの根を加熱還流し、濾
過して得ることができ、一般にはこの抽出液を濃縮して
使用する。このような方法で得られたアイリス抽出液は
、溶媒を留去後さらに、1.3−ブチレングリコールの
ような溶媒に溶解したり、または得られた液を適当に濃
縮した濃縮物として、本発明に使用することもできる。
An iris extract can be obtained by heating iris roots in a suitable solvent such as water, a lower alcohol such as methanol or ethanol, or a water-containing lower alcohol, followed by filtration. Concentrate the liquid before use. After the solvent is distilled off, the iris extract obtained by this method is further dissolved in a solvent such as 1,3-butylene glycol, or the obtained liquid is appropriately concentrated to form a concentrate. It can also be used for inventions.

別の方法として、アイリスの根を前記した適当な抽出溶
媒で抽出して得られる抽出物、あるいはアイリスの根を
熱水で抽出して得られる抽出物をシリカゲルクロマトグ
ラフィーなどの吸着系クロマトグラフィーを用いて分画
して得られた抽出物を用いることもできる。
Another method is to perform adsorption chromatography such as silica gel chromatography using an extract obtained by extracting iris roots with an appropriate extraction solvent as described above, or an extract obtained by extracting iris roots with hot water. An extract obtained by fractionation can also be used.

本発明に使用されるピリドキシンの誘導体、即ちビタミ
ンB6誘導体としては、ビタミンB6塩酸塩、ビタミン
B6ジオクタノエート、ビタミンB6  )リパルミテ
ート、ビタミンB6ジパルミテート、ビタミンB6ジラ
ウレート、リン酸ピリドキサール、グリチルレチン酸ピ
リドキシンなどをあげることができる。本発明において
ピリドキシン及びその誘導体は単独又は任意の混合物と
して用いることができる。
Examples of pyridoxine derivatives, ie, vitamin B6 derivatives used in the present invention include vitamin B6 hydrochloride, vitamin B6 dioctanoate, vitamin B6 lipalmitate, vitamin B6 dipalmitate, vitamin B6 dilaurate, pyridoxal phosphate, and pyridoxine glycyrrhetinate. I can do it. In the present invention, pyridoxine and its derivatives can be used alone or in any mixture.

本発明におけるピリドキシン又はその誘導体の配合量に
は特に限定はないが、好ましくは皮膚外用剤全量中に、
o、oos〜2重量%更に好ましくは、0.01〜1重
量%配合される。
There is no particular limitation on the amount of pyridoxine or its derivatives in the present invention, but preferably in the total amount of the skin external preparation,
o, oos to 2% by weight, more preferably 0.01 to 1% by weight.

一方本発明におけるアイリスの配合量にも特に限定はな
いが、一般には根の乾燥物を使用する場合には皮膚外用
剤全量中、o、ooi〜5重量%、根の抽出物を使用す
る場合には皮膚外用剤全量中o、oot〜10重量%(
更に好ましくは、0.01〜5重量%)使用するのが好
ましい。使用量が少なすぎると本発明における目的効果
が十分に発揮されない場合がある。
On the other hand, there is no particular limitation on the amount of iris to be blended in the present invention, but in general, when using the dried root product, it is from o, ooi to 5% by weight of the total amount of the skin external preparation, and when using the root extract. o, oot ~ 10% by weight of the total amount of the skin external preparation (
More preferably, it is used in an amount of 0.01 to 5% by weight. If the amount used is too small, the intended effects of the present invention may not be fully exhibited.

本発明の皮膚外用剤は、前記の必須成分に加えて、必要
に応じて、本発明の効果を損なわない範囲内で、化粧品
、医薬品等に一般に用いられる各種成分、例えば水性成
分、粉末成分、油分、界面活性剤、保湿剤、増粘剤、防
腐剤、酸化防止剤、香料、色剤、薬剤等を配合すること
ができる。薬剤の中でも特にビタミンB6又はその誘導
体を配合した時、顕著な効果が発揮される。
In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention may optionally contain various ingredients commonly used in cosmetics, pharmaceuticals, etc., such as aqueous ingredients, powder ingredients, etc., as long as they do not impair the effects of the present invention. Oils, surfactants, humectants, thickeners, preservatives, antioxidants, fragrances, colorants, drugs, etc. can be added. Among drugs, particularly when vitamin B6 or its derivatives are combined, remarkable effects are exhibited.

また本発明の皮膚外用剤の剤型は任意であり、例えば化
粧水等の可溶化系、乳液、クリーム等の乳化系あるいは
軟膏、分散液、粉末製品などの剤型をとることができる
Further, the dosage form of the skin external preparation of the present invention is arbitrary, and can be, for example, a solubilized system such as a lotion, an emulsified system such as a milky lotion or a cream, or a dosage form such as an ointment, a dispersion, or a powder product.

発明の実施例及び効果 以下に本発明の詳細な説明するが、本発明の範囲をこれ
らの実施例に限定するものでないことはいうまでもない
EXAMPLES AND EFFECTS OF THE INVENTION The present invention will be described in detail below, but it goes without saying that the scope of the present invention is not limited to these examples.

実施例1  :  化粧水 (処方) 成  分             %■アイリス抽出
物※       0.05■グリセリン      
    4.0■1.3−ブチレングリコール    
4.0■エタノール          7.0■ポリ
オキシエチレン オレイルアルコール      0.5■メチルパラベ
ン        0.05■クエン酸       
      0.01■クエン酸ソーダ       
  0.1■ビタミンB6塩酸塩      0.1[
相]香料             0.05■精製水
            84.14※ニアイリスの根
を充分水洗し、約5 mmに細切したちの10kgに4
0%エタノール801を加え、50℃で2日間浸漬した
。これを濾過し、濾液を40℃で5時間攪拌し、析出し
た沈澱物を濾過して除いた。、この濾液を50m11g
40℃にて減圧蒸留し、12kgとする。この液に1,
3−ブチレングリコール8 kgを加え、1時間攪拌し
た後、3日間静置し、濾過して得た。
Example 1: Lotion (prescription) Ingredients % ■ Iris extract * 0.05 ■ Glycerin
4.0■1.3-Butylene glycol
4.0 ■ Ethanol 7.0 ■ Polyoxyethylene oleyl alcohol 0.5 ■ Methyl paraben 0.05 ■ Citric acid
0.01 ■ Sodium citric acid
0.1 ■ Vitamin B6 hydrochloride 0.1 [
Phase] Fragrance: 0.05 ■Purified water: 84.14
0% ethanol 801 was added and immersed at 50°C for 2 days. This was filtered, the filtrate was stirred at 40°C for 5 hours, and the precipitate that had separated out was removed by filtration. , 11g of this filtrate in 50ml
Distill under reduced pressure at 40°C to weigh 12 kg. Add 1 to this liquid,
After adding 8 kg of 3-butylene glycol and stirring for 1 hour, the mixture was left standing for 3 days and filtered.

(製法) 精製水にクエン酸、クエン酸ソーダ、グリセリン、1.
3−ブチレングリコール、アイリス抽出物、ビタミンB
6塩酸塩を溶解した。別にエタノールにポリオキシエチ
レンオレイルアルコール、香料、メチルパラベンを溶解
し、これを前述の精製水溶液に加えて可溶化し、濾過し
て化粧水を得た。
(Manufacturing method) Citric acid, sodium citrate, glycerin, purified water, 1.
3-butylene glycol, iris extract, vitamin B
6 hydrochloride was dissolved. Separately, polyoxyethylene oleyl alcohol, fragrance, and methylparaben were dissolved in ethanol, and this was added to the above-mentioned purified aqueous solution to solubilize and filtered to obtain a lotion.

実施例2  ・  クリーム (処方) 成  分             %■セトステアリ
ルアルコール   3.5■スクワラン       
  40.0■ミツロウ           3.0
■還元ラノリン         5.0■エチルパラ
ベン        0.3■ポリオキシエチレン(2
0)ソルビタンモノパルミチン酸エステル   2.0
■ステアリン酸モノグリセリド  2.0■アイリス抽
出物※        1.0■香料        
     0.03[相]1.3−ブチレングリコール
    5.0■グリセリン          5.
0@ビタミンB6ジオクタノエート0.1■精製水  
         33.07※ニアイリスの根を充分
水洗し、約5mに細切したもの10kgに70%エタノ
ール100 i!を加え、50℃で2日間浸漬した。こ
れを濾過し、濾液を5QmHg40℃にて減圧蒸留し、
40kgとした。
Example 2 ・ Cream (formulation) Ingredients %■Cetostearyl alcohol 3.5■Squalane
40.0■Beeswax 3.0
■Reduced lanolin 5.0■Ethylparaben 0.3■Polyoxyethylene (2
0) Sorbitan monopalmitate ester 2.0
■Stearic acid monoglyceride 2.0 ■Iris extract* 1.0 ■Fragrance
0.03 [Phase] 1.3-Butylene glycol 5.0 ■ Glycerin 5.
0@vitamin B6 dioctanoate 0.1 ■Purified water
33.07 *Wash the roots of Niiris thoroughly and cut them into approximately 5m pieces. Add 10kg of 70% ethanol to 100 i! was added and immersed at 50°C for 2 days. This was filtered, and the filtrate was distilled under reduced pressure at 5QmHg at 40°C.
It was set to 40 kg.

(製法) 成分■、■、■、■、■、■、■、■を加熱溶解し75
℃に保ったものを、75℃に加温した■、0、■、[相
]と■に攪拌しながら加えた。ホモミキサー処理し乳化
粒子を細かくした後攪拌しながら急冷し、クリームを得
た。
(Production method) Heat and dissolve ingredients ■, ■, ■, ■, ■, ■, ■, ■75
The mixture kept at 75°C was added to (1), 0, (2), [phase] and (2) heated to 75°C with stirring. After treatment with a homomixer to make emulsified particles fine, the mixture was rapidly cooled while stirring to obtain cream.

実施例3  :  乳液 (処方) 一敷−−生一         % ■アイリス抽出物※       o、oot■ステア
リン酸          1.5■セチルアルコール
       0.5■ミツロウ          
 2.0■ポリオキシエチレン(10) モノオレイン酸エステル    1.0■グリセリン七
ノステアリン 酸エステル          1.0■クインスシー
ド抽出物 (5%水溶液)         20.0■プロピレ
ングリコール     5.0■エタノール     
     3.0[相]エチルパラベン       
 0.3■香料             0.03■
ビタミンB6塩酸塩      0.5■精製水   
         残余※ニアイリスの根を充分水洗し
、約5鶴に細切したもの5krに水10I!を加え、加
熱還流しく10時間)濾過し、得られた濾液を3日間静
置し、濾過し濾液に水を加え、全量1ONとした。
Example 3: Emulsion (formulation) Isshiki--Ichi % ■Iris extract* o, oot■Stearic acid 1.5■Cetyl alcohol 0.5■Beeswax
2.0 ■ Polyoxyethylene (10) Monooleic acid ester 1.0 ■ Glycerin heptanostearate 1.0 ■ Quince seed extract (5% aqueous solution) 20.0 ■ Propylene glycol 5.0 ■ Ethanol
3.0 [Phase] Ethylparaben
0.3■Fragrance 0.03■
Vitamin B6 hydrochloride 0.5 ■ Purified water
Remains *Niairis root thoroughly washed with water and cut into approximately 5 pieces. 5kr and 10I of water! The resulting filtrate was allowed to stand for 3 days, filtered, and water was added to the filtrate to make a total volume of 1ON.

(!I!法) エタノールに香料を加えて溶解した(アルコール相)。(!I! Law) Flavor was added and dissolved in ethanol (alcohol phase).

精製水にプロピレングリコール、アイリス抽出物、ビタ
ミンB6塩酸塩を加え加熱溶解し70℃に保った(水相
)。クインスシード抽出物を除く他の成分を)、 混合し、加熱溶解して70℃に保った(油相)。次に、
水相に油相を加え予備乳化を行い、ホモミキサーで均一
に乳化した。これを攪拌しながらアルコール相とクイン
スシード抽出物を加え、その後攪拌しなから30℃に冷
却して乳液を得た。
Propylene glycol, iris extract, and vitamin B6 hydrochloride were added to purified water, dissolved by heating, and kept at 70°C (aqueous phase). Other ingredients (except quince seed extract) were mixed, dissolved by heating and kept at 70°C (oil phase). next,
The oil phase was added to the water phase for preliminary emulsification, and the mixture was uniformly emulsified using a homomixer. The alcohol phase and quince seed extract were added to the mixture while stirring, and then the mixture was cooled to 30° C. without stirring to obtain a milky lotion.

実施例4  :  パンク (処方) 成  分             %■アイリス抽出
物※       0.1■ホリビニルアルコール  
   15.0■ポリエチレングリコール    3.
0■プロピレングリコール     7.0■エタノー
ル          10.0■メチルパラベン  
      0.05■香料            
 0.05■ビタミンB6ジオクタノエート0.3■精
製水           64.50※;アイリスの
根を充分水洗し、約5wに細切したちの10kgにメタ
ノール50Jを加え、50℃で2日間浸漬した。これを
濾過し、濾液をシリカゲルカラムに通した。さらに溶出
液を70%エタノールとし、201をシリカゲルカラム
に通し溶出液を得た。
Example 4: Punk (prescription) Ingredients % ■ Iris extract * 0.1 ■ Holivinyl alcohol
15.0 ■ Polyethylene glycol 3.
0 ■ Propylene glycol 7.0 ■ Ethanol 10.0 ■ Methyl paraben
0.05 ■Fragrance
0.05■Vitamin B6 dioctanoate 0.3■Purified water 64.50*; Iris roots were thoroughly washed with water and cut into pieces of about 5W. 50J of methanol was added to 10kg and immersed at 50°C for 2 days. This was filtered and the filtrate was passed through a silica gel column. Furthermore, the eluate was changed to 70% ethanol, and 201 was passed through a silica gel column to obtain an eluate.

(製法) 精製水にポリエチレングリコール、プロピレングリコー
ル、アイリス抽出物、メチルパラベンを加え攪拌熔解し
た。つぎにポリビニルアルコールを加え加熱攪拌し、ビ
タミンB6ジオクタノエート、香料を溶解したエタノー
ルを加え攪拌熔解してパックを得た。
(Production method) Polyethylene glycol, propylene glycol, iris extract, and methylparaben were added to purified water and dissolved with stirring. Next, polyvinyl alcohol was added and stirred with heating, and ethanol in which vitamin B6 dioctanoate and fragrance were dissolved was added and dissolved with stirring to obtain a pack.

実施例5:頭皮用化粧料(スカルプトリートメント)(
処方) 成   分             %■アイリス抽
出物※       0.5■1,3−ブチレングリコ
ール    6.5■ポリエチレングリコール1500
  5.0■エタノール          5.5■
苛性カリ            0.05■精製水 
          46.95■2−へキシルデシル
パルミテート 10.0■スクワラン        
  5.0■ブチルパラベン        0.2[
相]ビタミンc            o、is■香
料             0.05■精製水   
        18.9■カルボキシビニルポリマー
   0.2■ビタミンB6塩酸塩      1.0
※ニアイリスの根を充分水洗し、約5鶴に細切したもの
10kgに1.3−ブチレングリコール50j?を加え
、50℃で2日間浸漬した。これを濾過し、濾液を室温
で5時間攪拌し、析出した沈澱物を濾過して除去した。
Example 5: Scalp cosmetics (scalp treatment) (
Prescription) Ingredients % ■ Iris extract * 0.5 ■ 1,3-butylene glycol 6.5 ■ Polyethylene glycol 1500
5.0■Ethanol 5.5■
Caustic potash 0.05 ■ Purified water
46.95■2-hexyldecyl palmitate 10.0■Squalane
5.0■Butylparaben 0.2[
[Phase] Vitamin C o, IS■Fragrance 0.05■Purified water
18.9 ■ Carboxyvinyl polymer 0.2 ■ Vitamin B6 hydrochloride 1.0
*Wash Niiris root thoroughly and cut into approximately 5 pieces, then add 10kg of 1.3-butylene glycol to 50j? was added and immersed at 50°C for 2 days. This was filtered, the filtrate was stirred at room temperature for 5 hours, and the precipitate deposited was removed by filtration.

濾液は1,3−ブチレングリコールを加え、全量5゜l
とした。
Add 1,3-butylene glycol to the filtrate and bring the total volume to 5゜l.
And so.

(製法) 成分■、■、■、[相]と0を75℃で溶解したものを
、75℃に保った成分■、■、■、■、[相]と■に攪
拌しながら添加し、さらに室温で攪拌溶解した成分■、
@と成分@を添加し、攪拌しながら冷却してスヵルブト
リートメントを得た。
(Production method) Components ■, ■, ■, [phase] and 0 were dissolved at 75°C and added to the components ■, ■, ■, ■, [phase] and ■ kept at 75°C with stirring, Ingredients dissolved by stirring at room temperature
@ and ingredients @ were added and cooled while stirring to obtain a scalp treatment.

方伊6  :  軟膏 (処方) 成  分             %■アイリス抽出
物※       5.0■ステアリルアルコール  
   18.0■モクロウ           20
.0■ポリオキシエチレン(10) モノオレイン酸エステ;v     O,25■グリセ
リン七ノステアリン 酸エステル          0.25■ワセリン 
           40.0■ビタミンB6ジオク
タノエート 0.2■精製水           1
6.3※ニアイリスの根を熱水で抽出し、抽出物をシリ
カゲルのカラムに吸着後、メタノールで溶出したフラク
ションをメタノール留去後エタノールに溶解した。
Hoi 6: Ointment (prescription) Ingredients % ■ Iris extract * 5.0 ■ Stearyl alcohol
18.0 ■Mokurou 20
.. 0 ■ Polyoxyethylene (10) Monooleic acid ester; v O, 25 ■ Glycerin heptanostearate 0.25 ■ Vaseline
40.0 ■ Vitamin B6 dioctanoate 0.2 ■ Purified water 1
6.3*Niairis roots were extracted with hot water, the extract was adsorbed on a silica gel column, and the fraction eluted with methanol was dissolved in ethanol after distilling off the methanol.

(製法) 精製水を70℃に保ち(水相)、他の成分を70℃にて
混合溶解した。(油相)0次いで水相に油相を加え、ホ
モミキサーで均一に乳化後冷却して軟膏を得た。
(Manufacturing method) Purified water was maintained at 70°C (aqueous phase), and other components were mixed and dissolved at 70°C. (Oil phase) Next, the oil phase was added to the water phase, uniformly emulsified with a homomixer, and then cooled to obtain an ointment.

1h・ (以下余白) 実施例7  :  水性エツセンス (処方) 成  分             %(A)水   
         全量1001.3−ブチレングリコ
ール   5.OD、 P、 G          
5.0カルボキシビニルポリマー  0.2 ビタミンB6塩酸塩     0.2 アイリス抽出物※      2.0 (B)エタノール         1OPOE(60
)硬化ヒマシ油  1.0香料           
 0.1 メチルパラベン       0.2 (C)水酸化カリウム       0.1※ニアイリ
スの根を充分水洗し、約5鶴に細切したもの5蹟をさら
に粉砕し、得られた粉砕物をまず100メツシユの篩に
かけ、さらに325メツシユの篩にかけて平均粒子が約
40ミクロンの粉末的2 kgを得た。
1h (blank below) Example 7: Water-based essence (formulation) Ingredients % (A) Water
Total amount 1001.3-butylene glycol 5. OD, P, G
5.0 Carboxyvinyl polymer 0.2 Vitamin B6 hydrochloride 0.2 Iris extract* 2.0 (B) Ethanol 1 OPOE (60
) Hydrogenated castor oil 1.0 Fragrance
0.1 Methylparaben 0.2 (C) Potassium hydroxide 0.1 *Niairis roots were thoroughly washed with water and cut into approximately 5 pieces.The 5 pieces were further crushed. The mixture was sieved and passed through a 325 mesh sieve to obtain 2 kg of powder with an average particle size of about 40 microns.

(製法) (A)の水相部、(B)のアルコール相部をそれぞれ、
室温にて均一溶解した後、水相(A)にアルコール相(
B)を加え均一に混合、可溶化した後に成分(C)の水
酸化カリウムを加え中和増粘して水性エツセンスを得た
(Production method) The aqueous phase part of (A) and the alcohol phase part of (B), respectively,
After uniformly dissolving at room temperature, the alcohol phase (
After adding B) and uniformly mixing and solubilizing, component (C) potassium hydroxide was added to neutralize and increase the viscosity to obtain an aqueous essence.

実施例8  :  粉末製品 (処方) 成  分              %(A)タルク
            85.3二酸化チタン   
      2.0カオリン           2
.0アイリス粉砕物        5.0ビタミンB
e )リパルミテート 0.5メチルパラベン    
    0.1(B)スクワラン         5
.0香料             0.1(製法) 香料をスクワランに溶かし、(A)を混合したものにl
!1TiL、さらに混合し粉砕して粉末製品を得た。
Example 8: Powder product (formulation) Ingredients % (A) Talc 85.3 Titanium dioxide
2.0 Kaolin 2
.. 0 crushed iris 5.0 vitamin B
e) Lipalmitate 0.5 methylparaben
0.1(B) Squalane 5
.. 0 Fragrance 0.1 (Production method) Dissolve the fragrance in squalane and add (A) to the mixture.
! 1TiL was further mixed and ground to obtain a powder product.

肌荒れ改善効果 実施例1で得た化粧水と、実施例1の処方でアイリス抽
出物を配合しない(精製水で置換)化粧水及びビタミン
B6を配合しない(精製水で置換)化粧水とを用いて、
人体パネルで肌荒れ改善効果試験を行った。
Effect on improving rough skin Using the lotion obtained in Example 1 and the lotion without iris extract (replaced with purified water) and the lotion without vitamin B6 (replaced with purified water) with the formulation of Example 1. hand,
A skin improvement effect test was conducted using human body panels.

すなわち、女性健常人(顔面)の皮膚表面形態をミリス
ン樹脂によるレプリカ法を用いて肌のレプリカを取り顕
微鏡(17倍)にて観察した。
That is, the skin surface morphology of a healthy female subject (facial) was observed using a microscope (17x magnification) by taking a skin replica using the replica method using Millisne resin.

皮紋の状態及び角層の剥離状態から第1表に示す基準に
もとづいて肌荒れ評価1.2と判断された者(肌荒れパ
ネル)30名を用い、顔面左右率々に、実施例1で得た
化粧水とアイリス抽出物を配合しない化粧水またはビタ
ミンB6を配合しない化粧水を1日1回2週間塗布した
Using 30 people (skin roughness panel) who were judged to have a skin roughness rating of 1.2 based on the condition of skin markings and peeling of the stratum corneum based on the criteria shown in Table 1, the results obtained in Example 1 were used on both sides of the face. A lotion containing no iris extract or a lotion containing no vitamin B6 was applied once a day for two weeks.

2週間後、再び上述のレプリカ法にて肌の状態を観察し
、第1表の判定基準に従って評価した。
Two weeks later, the skin condition was observed again using the replica method described above and evaluated according to the criteria in Table 1.

結果は第2表に示した通りであった。The results were as shown in Table 2.

(以下余白) 第1表 評点  評 価   備考 l  皮溝、皮丘の消失 広範囲の角層のめくれ    肌荒れ 2  皮溝、皮丘が不鮮明 角層のめくれ 3  皮溝、皮丘は認められるが 平坦 4  皮溝、皮丘が鮮明 5  皮溝、皮丘が鮮明で整って  美しい肌いる (以下余白) 第2表 レプリカ   実施例1 アイリス ビタミン評  価
   化粧水  無    B6無1    0名  
 6名   10名2    0名   6名    
5名3    1名   8名   3名 4    3名   0名    2名5    16
名   0名   θ名筆2表の結果から、アイリス抽
出物及びビタミンB6配合の化粧水を使用した顔面部位
は他の化粧水を使用した顔面部位と比較し、顕著な肌荒
れ改善効果が認められることが明らかである。
(Margins below) Table 1 Score Evaluation Notes 1 Loss of skin grooves and duplexes Widespread peeling of the stratum corneum Skin roughness 2 Skin grooves and duplexes are unclear and peeling of the stratum corneum 3 Skin grooves and duplexes are observed but flat 4 Skin grooves and skin mounds are clear 5 Skin grooves and skin mounds are clear and well-organized Beautiful skin (see margins below) Table 2 Replica Example 1 Iris Vitamin evaluation Lotion None B6 None 1 0 people
6 people 10 people2 0 people 6 people
5 people 3 1 person 8 people 3 people 4 3 people 0 people 2 people 5 16
Name 0 people θ From the results in Table 2, it can be seen that facial areas treated with lotion containing iris extract and vitamin B6 have a remarkable effect on improving rough skin compared to facial areas treated with other lotions. it is obvious.

(以下余白)(Margin below)

Claims (1)

【特許請求の範囲】[Claims] 1、ピリドキシン又はその誘導体及びアイリス又はその
抽出液を配合して成ることを特徴とする皮膚外用剤。
1. A skin external preparation characterized by containing pyridoxine or its derivative and iris or its extract.
JP60093815A 1985-05-02 1985-05-02 External agent for skin Granted JPS61254510A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60093815A JPS61254510A (en) 1985-05-02 1985-05-02 External agent for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60093815A JPS61254510A (en) 1985-05-02 1985-05-02 External agent for skin

Publications (2)

Publication Number Publication Date
JPS61254510A true JPS61254510A (en) 1986-11-12
JPH0582365B2 JPH0582365B2 (en) 1993-11-18

Family

ID=14092894

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60093815A Granted JPS61254510A (en) 1985-05-02 1985-05-02 External agent for skin

Country Status (1)

Country Link
JP (1) JPS61254510A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000966B (en) * 1992-02-28 1993-03-16 Platon Dimitriou Process for the production of a preparation for the protection of the human skin.
EP0797985A1 (en) * 1996-03-27 1997-10-01 L'oreal Use of an extract of iridaceas in the treatment of skin wrinkles
ES2116243A1 (en) * 1996-12-24 1998-07-01 Vicente Rojas Isabel Ointment (pomade) for topical use, which can be applied to burns and skin complaints in general
US6419962B1 (en) * 1996-06-28 2002-07-16 Shiseido Company, Ltd. External skin treatment composition
WO2003082230A2 (en) * 2002-03-28 2003-10-09 The Procter & Gamble Company Topical use of vitamin b6 compositions

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000966B (en) * 1992-02-28 1993-03-16 Platon Dimitriou Process for the production of a preparation for the protection of the human skin.
EP0797985A1 (en) * 1996-03-27 1997-10-01 L'oreal Use of an extract of iridaceas in the treatment of skin wrinkles
WO1997035556A1 (en) * 1996-03-27 1997-10-02 L'oreal Use of an extract of at least one iridaceous plant for treating wrinkles
FR2746641A1 (en) * 1996-03-27 1997-10-03 Oreal USE OF AN EXTRACT OF AT LEAST ONE IRIDACEA IN THE TREATMENT OF WRINKLES
US6224850B1 (en) 1996-03-27 2001-05-01 Societe L'oreal S.A. Antiwrinkle cosmetic/pharmaceutical compositions comprising iridaceae extracts
US6419962B1 (en) * 1996-06-28 2002-07-16 Shiseido Company, Ltd. External skin treatment composition
ES2116243A1 (en) * 1996-12-24 1998-07-01 Vicente Rojas Isabel Ointment (pomade) for topical use, which can be applied to burns and skin complaints in general
WO2003082230A2 (en) * 2002-03-28 2003-10-09 The Procter & Gamble Company Topical use of vitamin b6 compositions
WO2003082230A3 (en) * 2002-03-28 2003-11-27 Procter & Gamble Topical use of vitamin b6 compositions

Also Published As

Publication number Publication date
JPH0582365B2 (en) 1993-11-18

Similar Documents

Publication Publication Date Title
JPH08119825A (en) Hydroxytyrosol, application for skin external medicine or bathing agent
JPH11263720A (en) Antiaging agent
JPH06199646A (en) Skin beautifying cosmetic
JP3817114B2 (en) Antioxidant and external preparation for skin containing the same
JPS5916816A (en) Composition for external use
JP3667027B2 (en) Topical skin preparation
JP2008247786A (en) External preparation for skin
JPH0532556A (en) Skin agent for external use
JP2001122733A (en) Catalase production-promoting preparation and skin preparation for external use containing the same
JPS61254510A (en) External agent for skin
JPS61205204A (en) External preparation for skin
JP2003137742A (en) Hair growing agent comprising evolvulus plant extract and other galenical extract
JP2000096050A (en) Promoter for production of hyaluronic acid
JP2000109417A (en) Cosmetic for improving somber color
JPH0643293B2 (en) External skin preparation
JP2003012495A (en) Cosmetic
JPH08133948A (en) Skin preparation for external use
JP2001131079A (en) Skin preparation for external use
JP2002068956A (en) Skin cosmetic
JPH04321616A (en) Skin medicine for external use
JP2000063226A (en) Skin preparation for external use
JP3799340B2 (en) Hydroxytyrosol, application to topical skin preparation
JPH02207012A (en) Cosmetic for preventing skin from aging
JPH04356416A (en) Skin cosmetic
JP2000143527A (en) Hyaluronic acid production promoter and skin preparation for external use containing the same

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees